Neuronetics (STIM) Shares Outstanding (Diluted Average) (2019 - 2026)

Neuronetics (STIM) has 8 years of Shares Outstanding (Diluted Average) data on file, last reported at $69.6 million in Q1 2026.

• Shares Outstanding (Diluted Average) for Q1 2026 came in at $69.6 million, up 13.22% year-over-year; the trailing twelve-month figure through Mar 2026 was $69.6 million (up 13.22% YoY), and the FY2025 annual result was $66.0 million, up 107.82% from the prior year.
• Shares Outstanding (Diluted Average) grew to $69.6 million in Q1 2026 per STIM's latest filing, from $66.0 million in the prior quarter.
• Over five years, Shares Outstanding (Diluted Average) peaked at $69.6 million in Q1 2026 and troughed at $26.6 million in Q1 2022.
• A 5-year average of $39.4 million and a median of $29.5 million in 2024 frame the typical range for Shares Outstanding (Diluted Average).
• The sharpest annual moves came in 2022 and 2025: Shares Outstanding (Diluted Average) gained 2.52% in 2022, then jumped 124.88% in 2025.
• A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $26.9 million in 2022, then rose by 6.54% to $28.7 million in 2023, then climbed by 10.73% to $31.7 million in 2024, then jumped by 107.82% to $66.0 million in 2025, then gained by 5.52% to $69.6 million in 2026.
• Business Quant data shows STIM's Shares Outstanding (Diluted Average) at $69.6 million in Q1 2026, $66.0 million in Q4 2025, and $67.3 million in Q3 2025.